JUNIOR STRENGTH ADVIL Drug Patent Profile
Which patents cover Junior Strength Advil, and when can generic versions of Junior Strength Advil launch?
Junior Strength Advil is a drug marketed by Haleon Us Holdings and is included in two NDAs.
The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There is one drug master file entry for this compound. Two hundred and fifty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Junior Strength Advil
A generic version of JUNIOR STRENGTH ADVIL was approved as ibuprofen by CONTRACT PHARMACAL on October 15th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for JUNIOR STRENGTH ADVIL?
- What are the global sales for JUNIOR STRENGTH ADVIL?
- What is Average Wholesale Price for JUNIOR STRENGTH ADVIL?
Summary for JUNIOR STRENGTH ADVIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 162 |
| Clinical Trials: | 31 |
| Patent Applications: | 4,012 |
| What excipients (inactive ingredients) are in JUNIOR STRENGTH ADVIL? | JUNIOR STRENGTH ADVIL excipients list |
| DailyMed Link: | JUNIOR STRENGTH ADVIL at DailyMed |
Recent Clinical Trials for JUNIOR STRENGTH ADVIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universitas Airlangga | N/A |
| University of Sao Paulo | NA |
| FG Brasil LTDA | Phase 2/Phase 3 |
Pharmacology for JUNIOR STRENGTH ADVIL
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for JUNIOR STRENGTH ADVIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | JUNIOR STRENGTH ADVIL | ibuprofen | TABLET, CHEWABLE;ORAL | 020944-002 | Dec 18, 1998 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Haleon Us Holdings | JUNIOR STRENGTH ADVIL | ibuprofen | TABLET;ORAL | 020267-002 | Dec 13, 1996 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for JUNIOR STRENGTH ADVIL
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases | Pedea | ibuprofen | EMEA/H/C/000549Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age. | Authorised | no | no | no | 2004-07-28 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
